Press release
HIV Diagnostics Market | Dynamics, Forecast, Analysis and Supply Demand 2024
HIV Diagnostics Market
The 2018 was undoubtedly one of the most remarkable years pertaining to the developments in HIV diagnostics market. The year witnessed a slew of technological advancements and collaborations aiming toward ending the AIDS epidemic, which is rightly touted as one of the most serious health concerns worldwide. HIV related causes, as per the World Health Organization, claimed approximately 940 000 lives in 2017 globally. At the end of 2017, 36.9 million people worldwide were diagnosed living with HIV, a disease that has claimed almost 35 million lives so far. In recognition of this alarming morbidity and mortality rate, the global health community in tandem with the regulatory bodies are striving hard to provide effective treatments and diagnostic approaches accessible to the HIV-infected individuals world over.
HIV diagnostics market size was valued at USD 2.9 billion in 2017 and is expected to witness 8.7% CAGR from 2018 to 2024.
Get a Sample Copy of this Report: @ https://www.gminsights.com/request-sample/detail/491
Low-and middle-income Economies are the most potential yet underpenetrated avenue for the HIV diagnostics industry players
As per UNAIDS, low-and middle-income countries have the highest ratio of people living with HIV. In 2017, 53% of the overall HIV-infected patient base were living in eastern and southern Africa, 16% in western and central Africa, 14% in Asia, and 6% in western and central Europe and North America. The statistics are a validation to the penetration scope of HIV diagnostics market participants in the low-and middle-income countries. These countries undoubtedly can be one of the most prominent recipients of the POC self-tests diagnostic approach, given a large pool of population in these countries burdened with either the unawareness of the epidemic or lack of treatment accessibility.
2018 Highlights of the HIV diagnostics industry penetration in low-and middle-income economies
Mylan's collaboration agreement with Atomo Diagnostics
In 2018, Mylan N.V., the renowned generic and specialty pharmaceuticals company, made it to the headlines post its announcement of collaborative agreement with Atomo Diagnostics. The deal was announced as a strategy to make point of care rapid self-tests accessible in the low-and middle income economies wherein people can be more aware about their HIV status and seek treatment based on the results. As a part of the deal, Mylan received rights for the commercialization of CE-Marked in-vitro diagnostic tests in more than 100 countries across Asia, the Middle East, Africa, the CIS and Latin America.
Kenya Medical Research Institute's (KEMRI) collaboration with Roche for establishment of an advanced HIV diagnostic laboratory
In a bid to achieve the elimination of AIDS and HIV from the country by 2030, KEMRI announced ITS collaboration with Swiss pharmaceutical giant, Roche to launch an advanced HIV testing laboratory. Dubbed as Cobas 8800, the new laboratory is claimed to test approximately 1 million people yearly. The launch is touted as one of its kind in terms of its rapidity, functionality, and accuracy. The deal also marked Kenya in the ranks of Uganda and South Africa which are the only African countries with Roche's hi-tech HIV diagnostic laboratory.
Browse Report Summary @ https://www.gminsights.com/industry-analysis/hiv-diagnostics-market
More Insigtful Info: https://www.marketwatch.com/press-release/statistics-of-hiv-diagnostics-market-covering-market-size-industry-share-numbers-regional-outlook-2024-2019-04-30
Innovative and technologically advanced product launches chiefly characterized the HIV diagnostics industry landscape in 2018
As per WHO, new HIV infections observed a decline of 36% between 2000-2017. During the same period, HIV related deaths fell by 38%, owing to ART (antiretroviral therapy). The numbers are undoubtedly a result of the conjoint efforts of the regulatory bodies as well as healthcare companies which are constantly developing accessible, convenient, and affordable POC tools to reach out to the HIV infected masses.
Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. HIV diagnostics industry 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Regional trends
Chapter 3. HIV Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorable regulatory landscape in the U.S.
3.3.1.2. Point-of-care (POC) HIV diagnostics development
3.3.1.3. Increasing number of blood transfusions and blood donations
3.3.1.4. Rising AIDS/HIV prevalence in low and middle-income countries
3.3.1.5. Increasing government initiatives for HIV awareness
3.3.2. Industry pitfalls and challenges
3.3.2.1. Low degree of penetration in underdeveloped market
3.4. Growth potential analysis
3.4.1. By product
3.5. Regulatory landscape
3.6. Technology landscape
3.6.1. Point of care tests (rapid tests)
3.6.2. Over-the-counter tests (OTC)
3.7. Reimbursement scenario
3.8. Pricing analysis
3.9. Porter's analysis
3.10. Competitive landscape, 2017
3.10.1. Strategy dashboard
3.11. PESTEL analysis
Smartphone's multifunctionality as a HIV detection tool
Toward the end of 2018, a new research from the Brigham and Women's Hospital launched a tool to diagnose HIV with the help of smartphones, setting a new benchmark in the technology landscape of HIV diagnostics market. The tool which uses a cellphone and nanotechnology to identify the virus is highly portable, affordable, and accessible especially for resource-limited economies. As per reliable reports, the accuracy of the platform was within specificity of 99.1% and 94/6% sensitivity at the clinically relevant threshold of 1,000 virus particles per mL. Reportedly, the total cost of the entire setup was less than $5 per test, making it a highly economic tool in the low-income countries.
Related Reports@
Genetic Testing Market: https://www.marketwatch.com/press-release/22-billion-by-2024-genetic-testing-market-set-for-massive-growth-2019-04-03
Clinical Laboratory Services Market: https://www.marketwatch.com/press-release/clinical-laboratory-services-market-2019-industry-analysis-share-growth-sales-trends-supply-forecast-to-2025-2019-09-09
Besides these developments, another pivotal factor that is estimated to drive the HIV diagnostics adoption and demand trends is the regulatory scenario. In fact, a favorable regulatory scenario along with the high-end healthcare infrastructure has made the U.S. one of the pivotal regions witnessing a rather profound expansion of HIV diagnostics market. As per a report by Global Market Insights, the U.S. HIV diagnostics market led the entire North America landscape, with a recorded share of USD 876.8 million in 2017. In the coming years, though the region will be one of the major growth pockets for HIV diagnostics market players, it is undeniable that the penetration rate would soar high in the emerging countries. On a global scale, Global Market Insights forecasts the HIV diagnostics market share to surpass USD 5 billion by 2024.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Diagnostics Market | Dynamics, Forecast, Analysis and Supply Demand 2024 here
News-ID: 1931428 • Views: …
More Releases from Global Market Insights Inc.
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application.
The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing…
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil.
Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy…
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024.
Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care.
Sulfosuccinates are mainly a mild type…
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness.
Request a sample of this research report @
https://www.gminsights.com/request-sample/detail/233
Top Key Players in The Market are:
Graphenea S.A., Applied Graphene Materials plc, ACS…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
